Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, LLS Enter Strategic Research Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec, LLS Enter Strategic Research Pact

Will support LLS Screen-to-Lead Program

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has entered into a research collaboration with The Leukemia & Lymphoma Society (LLS) to support one of LLS’s Screen-to-Lead Programs (SLP). Evotec will support selected programs and principal investigators with resources for high-throughput screening and optimization of small molecules into drug-like compounds. Financial details were not disclosed.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “We are excited to initiate this collaboration and support The Leukemia and Lymphoma Society and their investigators. We are confident that our experienced scientists and innovation platform can deliver results for LLS, their investigators and ultimately patients.”
 
Amy Burd, Ph.D., executive director of research at LLS, added, “LLS is pleased to be working in collaboration with Evotec to advance our Screen-to-Lead programs. We feel that Evotec has the necessary skills and capabilities to offer significant value to support these projects.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics